Diseases [C] » Pathological Conditions, Signs and Symptoms [C23] » Pathologic Processes » Inflammation
Description
A pathological process characterized by injury or destruction of tissues caused by a variety of cytologic and chemical reactions. It is usually manifested by typical signs of pain, heat, redness, swelling, and loss of function. MeSH
Hierarchy View
Subtype Terms (9)
Acute-Phase Reaction
4 experimental drugs
Foreign-Body Reaction
1 approved drug
Neurogenic Inflammation
1 experimental drug
Neuroinflammatory Diseases
4 drugs (1 approved, 3 experimental)
Seroma
8 drugs (7 approved, 1 experimental)
Systemic Inflammatory Response Syndrome
42 drugs (27 approved, 15 experimental)
Approved Indicated Drugs (18)
Phase 4 Indicated Drugs (116)
Phase 3 Indicated Drugs (54)
Phase 1 Indicated Drugs (58)
Organization Involved with Phase 4 Indications (218)
American College of Clinical Pharmacy
Aristotle University of Thessaloniki
Boryung Pharmaceutical Company
CardioVascular Research Foundation, Korea
Chinese University of Hong Kong
Effice Servicios Para la Investigacion S.L.
Finnish Foundation for Cardiovascular Research
Fundació Investigació de les Illes Balears
Fundacio Lluita Contra la SIDA
Hospital General Universitario Gregorio Marañon
Hospital Universitario Ramon y Cajal
Huazhong University of Science and Technology
Iladevi Cataract and IOL Research Center
Innovative Medical Research of South Florida, Inc
Instituto de Medicina Integral Professor Fernando Figueira
Instituto di Biomedicina ed immunologia molecolare
Istituto di Biomedicina e Immunologia Molecolare Alberto Monroy
Istituto per la Ricerca e l'Innovazione Biomedica
Jiangsu Chia-tai Tianqing Pharmaceutical Co.,Ltd
Laboratorios Sophia S.A de C.V.
Medical University of South Carolina
National Center for Complementary and Integrative Health (NCCIH)
National Cheng Kung University
National Defense Medical College, Japan
National Heart, Lung, and Blood Institute (NHLBI)
National Institute of Allergy and Infectious Diseases (NIAID)
National Institute of Mental Health (NIMH)
National Institutes of Health (NIH)
Nizam's Institute of Medical Sciences, Hyderabad, India
Oregon Health and Science University
Rebeca Gonelli Albanez da Cunha Andrade
Retina Vitreous Associates of Florida
Retina Vitreous Surgeons of Central New York, PC
Rio de Janeiro State University
Santa Maria Nuova Hospital IRCCS
Scottish Centre for Respiratory Reseach
Shahid Beheshti University of Medical Sciences
Sociedad Española de Neumología y Cirugía Torácica
Spanish Research Center for Respiratory Diseases
Stanley Medical Research Institute
State University of New York, Buffalo
Steno Diabetes Center Copenhagen
Taipei Veteran General hospital
Taiyuan Fourth People's Hospital
Technical University of Dresden
The Gustavus and Louise Pfeiffer Research Foundation
The Korean Urological Association
University Hospital of North Norway
University of Alabama, Birmingham
University of British Columbia
University of California, San Francisco
University of Illinois at Chicago
University of Modena and Reggio Emilia
University of North Carolina at Chapel Hill
University of Roma La Sapienza
University of Science Malaysia
University of Southern California
University of Western Australia
Virginia Polytechnic Institute and State University
Organization Involved with Phase 3 Indications (168)
Ache Laboratorios Farmaceuticos S.A.
Adapt Produtos Oftalmológicos Ltda.
Allergisa Pesquisa Dermato-Cosmetica LTDA
Bambino Gesù Hospital and Research Institute
Canadian Institutes of Health Research (CIHR)
Case Western Reserve University
D'Annunzio University of Chieti–Pescara
Department of Medical Research, Lower Myanmar
Federal University of Minas Gerais
Federal University of Rio Grande do Sul
Health Research Board, Ireland
Hoosier Cancer Research Network
Icahn School of Medicine at Mount Sinai
Institut National de la Santé Et de la Recherche Médicale, France
Instituto Mexicano del Seguro Social
Instituto Nacional de Cardiologia Ignacio Chavez
Instituto Nacional de Rehabilitacion
Iran University of Medical Sciences
John-Kenyon American Eye Institute
Katholieke Universiteit Leuven
KLE Society's Institute of Dental Sciences
Kozlovsky Delay & Winter Eye Consultants, LLC
Los Angeles Biomedical Research Institute
Mashhad University of Medical Sciences
National Center for Research Resources (NCRR)
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
National Institute on Aging (NIA)
Office of Dietary Supplements (ODS)
Ontario Neurotrauma Foundation
Ophthalmic Consultants of Long Island
Rochester Ophthalmological Group, PC
Singapore Clinical Research Institute
the Flanders Institute for Biotechnology
The Foundation Institute San Raffaele G. Giglio of Cefalù
United States Department of Agriculture
Universidade Estadual de Londrina
University of California, Berkeley
University of California, Davis
University of California, Los Angeles
University of Colorado, Denver
University of Erlangen-Nuremberg
University of Naples Frederico II
University of Nice Sophia Antipolis
Wolstan & Goldberg Eye Associates
Organization Involved with Phase 2 Indications (194)
Advanced Regenerative Medicine
Biomedical Development Corporation
Canadian Research & Education in Arthritis
Centre Hospitalier Intercommunal de Toulon La Seyne sur Mer
Chinese Academy of Medical Sciences
CIHR Canadian HIV Trials Network
Clinical Trials in Organ Transplantation
Cystic Fibrosis Foundation Therapeutics
Daewon Pharmaceutical Co., Ltd.
Eastern Virginia Medical School
Firestone Institute for Respiratory Health
Guangzhou Four-Leaf Clover HealthTech Co., Ltd.
Hospital Santa Marcelina, Sao Paulo, Brasil
Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran
Integra LifeSciences Corporation
Iovate Health Sciences International Inc
JP Moulton Charitable Foundation
Juvenile Diabetes Research Foundation
Manhattan Eye, Ear & Throat Hospital
Moorgreen Hospital, Southampton
National Cancer Institute (NCI)
National Center for Advancing Translational Science (NCATS)
National Institute for Health Research, United Kingdom
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
National Institute of Dental and Craniofacial Research (NIDCR)
National Institute of Neurological Disorders and Stroke (NINDS)
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
National Institute on Drug Abuse (NIDA)
Neuraltus Pharmaceuticals, Inc.
Northern Ireland Clinical Trials Unit
Ontario Institute for Regenerative Medicine (OIRM)
Papworth Hospital NHS Foundation Trust
Queen Elizabeth Hospital NHS Foundation Trust
Ragon Institute of MGH, MIT and Harvard
Richardson Centre for Functional Foods and Nutraceuticals
Saskatchewan Health Research Foundation
Shenzhen maternal and child health care hospital
Southampton University Hospital NHS Foundation Trust
Stichting Astma Bestrijding, The Netherlands
Organization Involved with Phase 1 Indications (42)
Organization Involved with Other Experimental Indications (182)
Agriculture and Agri-Food Canada
Agroscope Liebefeld-Posieux Research Station ALP
A.O. Ospedale Maggiore di Lodi
California Strawberry Commission
Canadian Anesthesiologists' Society
Cantonal Hospital of St. Gallen
Centro de Pesquisas Oncológicas de Florianópolis
Clinica Universidad de Navarra
Collective Healthcare Solutions, LLC
Cornerstone Naturopathic Clinic Inc.
Environmental Protection Agency
European Research Advisory Board
Federal University of Rio de Janeiro
Fundação de Amparo à Pesquisa do Estado de São Paulo
HBT Medical College & R.N.Cooper Muncipal Hospital
Heart and Stroke Foundation of Canada
Illinois Institute of Technology
Institute of Sports Medicine, Copenhagen
Instituto Nacional de Enfermedades Respiratorias
Institut technique d'études et de recherches des corps gras
International Center for Diarrheal Disease Research
International Hyperbarics Association
Kronos Longevity Research Institute
Louisiana Health Care Practitioners, LLC
National Institute of Nutrition, Vietnam
National Nutrition and Food Technology Institute
New York City Health and Hospitals Corporation
Nicolaus Copernicus University
Novum Pharmaceutical Research Services
Pennington Biomedical Research Center
Regional Research Fund Western Norway
Silesian University of Medicine
Swedish Council for Working Life and Social Research
Swiss Federal Institute of Technology
Tandlaegeforeningen, Calcin fonden
The John van Geest Cancer Research Centre
The Swedish Society of Medicine
Uniformed Services University of the Health Sciences
Universidad Católica San Antonio de Murcia
Universidade Estadual de Ponta Grossa
University Hospitals Cleveland Medical Center
University of Mary Hardin-Baylor
University of Monterrey, Mexico
University of Southern Denmark
U.S. Highbush Blueberry Council
Hierarchy Tree View
UMLS Data
YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED “AS IS”, WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.
